262
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry for Simultaneous Determination of Antipsychotic Drugs in Human Plasma and Its Application in Therapeutic Drug Monitoring

& ORCID Icon
Pages 463-479 | Published online: 12 Feb 2021

References

  • LafargaT, O’ConnorP, HayesM. In silico methods to identify meat-derived prolyl endopeptidase inhibitors. Food Chem. 2015;175:337–343. doi:10.1016/j.foodchem.2014.11.15025577089
  • EwertzonM, HansonE. Support interventions for family members of adults with mental illness: a narrative literature review. Issues Ment Health Nurs. 2019;40(9):768–780. doi:10.1080/01612840.2019.159154731145025
  • HöhlW, MollS, PfeifferA. Occupational therapy interventions in the treatment of people with severe mental illness. Curr Opin Psychiatry. 2017;30(4):300–305. doi:10.1097/YCO.000000000000033928459731
  • XuZY, HuangFF, KöstersM, NicolasR. Challenging mental health related stigma in China: systematic review and meta-analysis. II. Interventions among people with mental illness. Psychiatry Res. 2017;255:457–464. doi:10.1016/j.psychres.2017.05.00228780128
  • PardisP, RemingtonG, PandaR, LemezM, AgidO. Clozapine and tardive dyskinesia in patients with schizophrenia: a systematic review. J Psychopharmacol. 2019;33:1187–1198. doi:10.1177/026988111986253531347436
  • ButlerM, UrosevicS, DesaiP, et al. Treatment for bipolar disorder in adults: a systematic review. Agency for Healthcare Research and Quality (US) 2018.
  • NagaiG, MiharaK, NakamuraA, et al. Prediction of an optimal dose of aripiprazole in the treatment of schizophrenia from plasma concentrations of aripiprazole plus its active metabolite dehydroaripiprazole at week 1. Ther Drug Monit. 2017;39(1):62–65. doi:10.1097/FTD.000000000000035827861318
  • MauriMC, PalettaS, MaffiniM, et al. Clinical pharmacology of atypical antipsychotics: an update. Excli J. 2014;13:1163–1191.26417330
  • ZhangL, LiYG, HeS, et al. Quantitative efficacy of three antipsychotic drugs for schizophrenia based on a real-world study in China. Acta Pharmacol Sin. 2019;40(12):1611–1620. doi:10.1038/s41401-019-0285-x31388088
  • HanM, DengC. BDNF as a pharmacogenetic target for antipsychotic treatment of schizophrenia. Neurosci Lett. 2020;726:133870. doi:10.1016/j.neulet.2018.10.01530312750
  • XuQQ, WuX, XionYY, et al. Pharmacogenomics can improve antipsychotic treatment in schizophrenia. Front Med. 2013;7(2):180–190. doi:10.1007/s11684-013-0249-323606027
  • SilvaMA, KeyS, HanE, MalloyM. Acute pancreatitis associated with antipsychotic medication: evaluation of clinical features, treatment, and polypharmacy in a series of cases. J Clin Psychopharmacol. 2016;36(2):169–172. doi:10.1097/JCP.000000000000045926859276
  • AlvesMD, Micoulaud-FranchiJA, SimonN, Vion-DuryJ. Electroencephalogram modifications associated with atypical strict antipsychotic monotherapies. J Clin Psychopharmacol. 2018;38(6):555–562. doi:10.1097/JCP.000000000000095330247179
  • ParikhT, GoyalD, ScarffJR, LippmannS. Antipsychotic drugs and safety concerns for breast-feeding infants. South Med J. 2014;107(11):686–688. doi:10.14423/SMJ.000000000000019025365434
  • GrundmannM, KacirovaI, UrinovskaR. Therapeutic drug monitoring of atypical antipsychotic drugs. Acta Pharm. 2014;64(4):387–401. doi:10.2478/acph-2014-003625531781
  • HiemkeC, BergemannN, ClementHW, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51(1–2):9–62. doi:10.1055/s-0043-11649228910830
  • JönssonAK, SpigsetO, ReisM. A compilation of serum concentrations of 12 antipsychotic drugs in a therapeutic drug monitoring setting. Ther Drug Monit. 2019;41(3):348–356. doi:10.1097/FTD.000000000000058531025986
  • SpinaE, HiemkeC, de LeonJ. Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics. Expert Opin Drug Metab Toxicol. 2016;12(4):407–422. doi:10.1517/17425255.2016.115404326878495
  • BustilloM, ZabalaA, QuerejetaI, et al. Therapeutic drug monitoring of second-generation antipsychotics for the estimation of early drug effect in first-episode psychosis: a cross-sectional assessment. Ther Drug Monit. 2018;40(2):257–267. doi:10.1097/FTD.000000000000048029369974
  • BogersJP, BuiH, HerruerM, CohenD. Capillary compared to venous blood sampling in clozapine treatment: patients and healthcare practitioners experiences with a point‐of‐care device. Eur Neuropsychopharmacol. 2015;25(3):319–324. doi:10.1016/j.euroneuro.2014.11.02225548103
  • HiemkeC, BaumannP, BergemannN, et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry. 2011;44(6):195–235. doi:10.1055/s-0031-1286287
  • RemmerieB, De MeulderM, WeinerS, SavitzA. Comparison of capillary and venous drug concentrations after administration of a single dose of risperidone, paliperidone, quetiapine, olanzapine, or aripiprazole. Clin Pharmacol Drug Dev. 2016;5(6):528–537. doi:10.1002/cpdd.29027365164
  • PatteetL, CappelleD, MaudensKE, et al. Advances in detection of antipsychotics in biological matrices. Clin Chim Acta. 2015;441:11–22. doi:10.1016/j.cca.2014.12.00825512162
  • TronC, KloosterboerSM, van der NagelBC, et al. Dried blood spots combined with ultra-high-performance liquid chromatography mass spectrometry for the quantification of the antipsychotics risperidone, aripiprazole, pipamperone, and their major metabolites. Ther Drug Monit. 2017;39(4):429–440. doi:10.1097/FTD.000000000000041128700523
  • NaharL, OnderA, SarkerSD. A review on the recent advances in HPLC, UHPLC and UPLC analyses of naturally occurring cannabinoids (2010–2019). Phytochem Anal. 2020;31(4):413–457. doi:10.1002/pca.290631849137
  • MeiYB, LuoSB, YeLY, et al. Validated UPLC-MS/MS method for quantification of fruquintinib in rat plasma and its application to pharmacokinetic study. Drug Des Devel Ther. 2019;13:2865–2871. doi:10.2147/DDDT.S199362
  • ZhouW, LiSL, ZhaoT, et al. Effects of dexmedetomidine on the pharmacokinetics of dezocine, midazolam and its metabolite 1-hydroxymidazolam in beagles by UPLC-MS/MS. Drug Des Devel Ther. 2020;14:2595–2605. doi:10.2147/DDDT.S254055
  • MoussaBA, MahrouseMA, FawzyMG. A validated LC-MS/MS method for simultaneous determination of linagliptin and metformin in spiked human plasma coupled with solid phase extraction: application to a pharmacokinetic study in healthy volunteers. J Pharm Biomed Anal. 2019;163:153–161. doi:10.1016/j.jpba.2018.09.05230312887
  • European Medicines Agency. Guideline on bioanalytical method validation. 2011.
  • U.S. Food and drug administration, bioanalytical method validation. Guidance for Industry; 2018.
  • ZhangXD, XiangQ, ZhaoX, MaLY, CuiYM. Association between aripiprazole pharmacokinetics and CYP2D6 phenotypes: a systematic review and meta-analysis. J Clin Pharm Ther. 2019;44(2):163–173. doi:10.1111/jcpt.1278030565279
  • Na TakuathungM, HanprasertpongN, TeekachunhateanS, KoonrungsesomboonN. Impact of CYP1A2 genetic polymorphisms on pharmacokinetics of antipsychotic drugs: a systematic review and meta-analysis. Acta Psychiatr Scand. 2019;139(1):15–25. doi:10.1111/acps.1294730112761